Parents of children with cancer have unmet information needs regarding future limitations resulting from cancer or its treatment. Prior research has demonstrated that, in early care discussions, clinicians focus on the acute effects of therapy rather than long-term limitations, partly due to worries of causing distress. The validity of concerns regarding distress is unknown. In the current study, the authors evaluated parental distress associated with information regarding future limitations, and the extent to which distress is associated with information preferences. METHODS: The authors surveyed 355 parents of children with cancer within 3 months of diagnosis, and the children's physicians at Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and the Children's Hospital of Philadelphia. The primary outcome was parental distress associated with information regarding long-term limitations. RESULTS: Approximately 46% of parents found information regarding future limitations to be extremely or very upsetting. In multivariate analysis, parents were more likely to consider information regarding future limitations distressing if they also found prognostic information upsetting (odds ratio [OR], 5.36; P<.001), struggled to accept their child's illness (OR, 2.57; P<.001), or had depression (OR, 1.79; P=.01). However, approximately 92% of parents considered information regarding potential future limitations to be extremely/very important. Those who found information regarding future limitations distressing were more likely to consider it important (96% vs 89%; P=.03) and to desire a precise understanding of their child's risks (92% vs 80%; P=.001). CONCLUSIONS: Although information regarding future limitations caused by cancer treatment is upsetting to many parents, the majority of them desire this information, and those who are distressed are more likely to value this information. Cancer 2018;124:4529-4537
INTRODUCTION
The time surrounding a child's cancer diagnosis can be overwhelming to parents. 1 Beyond the news of the diagnosis, early treatment conversations frequently touch on sensitive topics such as the child's prognosis and the short-term and long-term risks of therapy. [1] [2] [3] Parents who are emotionally overwhelmed may struggle to process and incorporate the news of the cancer and the fact that treatment may have life-long consequences. 4 Prior studies have suggested that parents value information regarding the late effects from the time of diagnosis, 3, 5, 6 but believe they receive suboptimal information concerning the future implications of their children's treatment. 7 This may be in part because providers offer less information concerning late effects than acute toxicities during early treatment conversations. 8 Furthermore, clinicians often describe the probabilities of specific late effects of treatment by individual chemotherapeutic agents, yet parents worry about the functional implications of the treatment as a whole 9 and the potential impact on their children's lives. 10 The gap between parent communication preferences regarding future limitations and the information they receive may be due in part to provider concerns regarding discussing potential impairment. Providers often hesitate to discuss late effects throughout the cancer care continuum due to concerns about overwhelming patients with information and causing distress. 11, 12 Furthermore, many physicians find it stressful to anticipate and communicate a patient's likely outcomes, 13 and fear taking away hope. 14 Even in survivorship clinics, oncologists tend to focus on current symptoms, rather than providing information regarding potential future health risks. 15 As rates of cure for childhood cancer continue to improve, it is ever more important that we meet parents' information needs regarding the long-term health implications of cancer and its treatment. Currently, greater than 80% of children with cancer will become long-term survivors, 16 and the majority will experience at least 1 late effect of cancer treatment. 17 In the current study, we sought to evaluate the emotional impact of early conversations regarding
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MATERIALS AND METHODS
We surveyed the parents of children with cancer and the children's pediatric oncologists at Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and the Children's Hospital of Philadelphia regarding their medical communication experiences. Questionnaires were administered between November 2008 and April 2014. Parents were approached about participation 1 to 6 weeks after their child's initial diagnosis, and surveys were administered within 12 weeks. Eligibility criteria included child age ≤18 years, ability of the parent to read English or Spanish, and permission to approach being granted by the child's primary oncologist. Eligible parents were approached in person during clinic visits or by mail, and given a letter describing participation, the questionnaire, and a postage-paid postcard to decline participation. Parents who did not respond initially were approached a second time. One parent per child completed the survey. After a parent completed a survey, their child's primary oncologist was approached with the paired physician survey. As a token of appreciation, participating parents received a $10 gift card, and physician participants received a $5 gift card. The institutional review boards of the Dana-Farber Cancer Institute and the Children's Hospital of Philadelphia approved the current study and informed consent was obtained from each participant. Parent and physician survey instruments used items or modified items drawn from previously developed questionnaires. 7, 18, 19 Limited novel items were developed after literature review, using general principles of survey design. The 75-item parent survey was pilot tested with parents to assess face and content validity, and took approximately 30 to 40 minutes to complete. Parent and oncologist surveys were available in paper-and-pencil or electronic formats as per participant preference; parent surveys were available in English or Spanish. Surveys initially were written in English, translated into Spanish, and then back-translated into English to ensure translation accuracy.
Study Outcomes
The primary outcome for this analysis was parental distress associated with information regarding future limitations, as assessed by a single survey item. Parents were asked how upsetting it was "to know information about how likely it is that cancer or its treatment may affect your child's life in the future," with response options of extremely, very, somewhat, a little, and not at all. This item was a modified version of an item previously used to assess distress associated with prognostic information. 18 The secondary outcome was parent information preferences regarding future limitations, which was assessed using 2 previously used items. 20 Parents were asked the importance of knowing "how likely it is that cancer or its treatment may affect your child's life in the future" and the importance of "having a precise understanding" of the likelihood of future limitations.
Explanatory Factors
We assessed the following factors, which we hypothesized may be associated with parents finding information regarding future limitations upsetting:
Parent perception of information quality was assessed using a previously developed 5-item scale (α=.87) with items querying the quality of information received regarding treatment, cause of cancer, likelihood of cure, likelihood of future limitations, and overall, with response options of excellent, good, satisfactory, fair, or poor. 21 Parent perception of communication quality was assessed using a previously developed scale (α=.76) that asked how often the oncologist provides understandable answers to questions, takes adequate time to answer questions, and conveys information in a sensitive manner, with response options of never, sometimes, usually, or always. 21 Trust in the child's oncologist was assessed using an item from the Trust in Physician scale. 22, 23 Parents and physicians were asked about the child's likelihood of cure, and the likelihood of him or her experiencing future limitations in "physical abilities (such as difficulty exercising)," "intelligence (such as difficulty with schoolwork)," and "quality of life (such as difficulty enjoying time with family or friends)." 20, 24 Physicianreported prognosis estimations were dichotomized as "favorable" (>75% chance of cure) or "less favorable" (<75% chance of cure) to approximate median survival estimates for all children with cancer. As described in prior analyses, the physician-reported likelihood of future limitations in each domain was trichotomized as "high risk" (≥50% chance of future limitations), "moderate risk" (10%-49% chance of future limitations), and "low risk" (≤10% chance of future limitations). 25 Distress related to prognostic information was assessed by asking parents "how upsetting is it to you to Cancer December 1, 2018 know information about your child's likelihood of cure?" (extremely, very, somewhat, a little, or not at all). 18 Parental peaceful acceptance and struggle with illness was assessed using the validated Peace, Equanimity, and Acceptance in the Cancer Experience (PEACE) scales; the 7-item struggle with illness subscale (α=.81); and the 5-item peaceful acceptance subscale (α=.78). 26 Parental depression and anxiety were assessed using the 14-item Hospital Anxiety and Depression Scale (HADS) (α=.92). 27, 28 Parent and child attributes including parent sex, age, educational level, and race/ ethnicity were obtained by questionnaire. Previously validated scales were used to assess parent dispositional optimism (6-item scale), 29 decisional regret (5-item scale), 30 and decision-making preferences and role (2-item scale). 31 Child sex, diagnosis, date of diagnosis, and date of birth were obtained by medical record review.
Statistical Analysis
Parental distress associated with information regarding potential future limitations was dichotomized as highly upsetting (extremely/very) versus somewhat, a little, or not at all. Univariable and multivariable logistic regression analyses were used to evaluate factors associated with parental distress. Backward selection was used to construct the multivariable model, setting the significance level for removal to .05, and including parent educational level, parent race/ethnicity, and child diagnosis categories in the model regardless of statistical significance. Variances of parameter estimates were obtained using a sandwich estimator to correct for within-physician clustering. Similar univariable analyses were performed to investigate whether information preferences differed by parental distress related to future limitations.
Item nonresponse was ≤7% for all items. Missing values were imputed by multiple imputation by chained equations, using the "ice" command in Stata statistical software (StataCorp LLC, College Station, Texas). Imputed values were used only for regression analyses and not for descriptive statistics; moreover, values for the outcome variable (parental distress) were not imputed. Statistical analyses were performed using Stata statistical software (version 13.1; StataCorp LLC).
RESULTS
Of the 565 eligible parents, approximately 68% (382 parents) completed the survey within 12 weeks of their child's diagnosis (mean, 6 weeks after diagnosis), and 95 oncologists completed paired surveys for 361 of these 382 patients (95%). Six surveys were excluded because the parents did not respond to the primary outcome of the current analysis, for a final study cohort of 355 parentphysician pairs. The parents of children with hematologic malignancies, extracranial solid tumors, and brain tumors were equally likely to participate, although there was a borderline association toward decreased participation among the parents of children with brain tumors (P=.07). The majority of parent respondents were female, (4) a Data were missing for the following: child sex (1 patient), parent age (7 parents), parent sex (3 parents), parent race/ethnicity (3 parents), parent educational level (7 parents), and parent marital status (6 parents).
Cancer December 1, 2018 Cancer December 1, 2018 married, and highly educated (Table 1 ). Oncologists considered approximately 22% of the children to be at high risk of physical limitations, 9% to be at high risk of impaired intelligence, and 6% to be at high risk of limitations in quality of life. Nearly one-half of the parents (46%; 165 of 355 parents) found information regarding potential future limitations due to cancer or its treatment to be extremely or very upsetting. In bivariable analyses, parental distress related to future limitations was not found to be significantly associated with physician estimates of the child's prognosis or the child's risk of future limitations (Table 2 ). However, parents who found prognostic information upsetting (35%; 121 of 348 parents) also tended to find information regarding future limitations upsetting (odd ratio [OR], 5.64; 95% confidence interval [95% CI], 3.78-8.42). Distress concerning future limitations also was found to be more likely among parents who struggled to accept their child's illness (OR, 2.95; 95% CI, 1.9-4.56) and those with depression (OR, 2.52; 95% CI, 1.65-3.85) and anxiety (OR, 1.87; 95% CI, 1.17-2.98). In contrast, parents reported less distress if they played a passive role in decision making compared with the oncologist (OR, 0.57; 95% CI, 0.36-0.89), and if they reported peaceful acceptance of the child's illness (OR, 0.43; 95% CI, 0.3-0.63).
Continued
In a multivariable logistic regression model (Table 3) , parents were found to be more likely to consider information regarding future limitations upsetting if they were upset by prognostic information (OR, 5.36; 95% CI, 3.34-8.6), if they struggled to accept their child's illness (OR, 2.57; 95% CI, 1.53-4.31), and if they had HADS scores suggestive of depression (OR, 1.79; 95% CI, 1.18-2.72). Parents who believed they played a passive role in decision making were less likely to be upset by information regarding future limitations (OR, 0.52; 95% CI, 0.3-0.94).
Despite the prevalence of distress, approximately 92% of parents believed information regarding longterm limitations was extremely or very important, and 86% desired a precise understanding of possible future limitations. Parents who found information regarding future limitations to be extremely or very upsetting were more likely to consider this information important (OR, 2.83; 95% CI, 1.12-7.15), and were more likely to value a precise understanding of the risk of future limitations (OR, 2.90; 95% CI, 1.58-5.29) compared with parents who were less upset by this information (Table 4) .
DISCUSSION
Nearly one-half of the parents in the current study considered information regarding future limitations resulting from cancer or its treatment to be upsetting. However, those who were distressed by this information expressed a greater desire for detailed information concerning longterm outcomes. Many oncologists worry that providing information regarding potential future limitations may upset parents, 11, 12 and although the results of the current study support this as a legitimate concern, they also suggest that parental distress should not be considered a reason to avoid conversations. Instead, parents who are distressed may need more information, or an opportunity to have continued discussions over time.
We identified risk factors for parents who found information regarding future limitations to be upsetting. For example, parents who experience depression, those who struggle with their child's diagnosis, and those who are upset by prognostic information may benefit from added emotional support overall, and in particular care in presenting information regarding future limitations. In addition, we found that parents who played a more passive role in decision making were less likely to be upset by information regarding late effects. Research suggests that individuals experience greater regret for decisions for which they feel more responsibility, 32 a phenomenon that may be at work in this case. Parents who felt less engaged in decisions may have felt less responsibility for potential outcomes, and subsequently less distressed. It is interesting to note that communication and information quality were not found to be associated with distress.
Although we identified an association between distress and a desire for more detailed information regarding long-term outcomes, we do not know the direction of this association and cannot speak to causation. Prior studies have suggested some potential mechanisms for the association. First, it is possible that inadequate information The model was determined using a backward selection procedure in which the significance level for removal from the model was set at .05; parent educational level, parent race/ethnicity, and diagnosis category were forced into the model regardless of statistical significance. ORs >1 represent a higher likelihood of finding information regarding future limitations to be extremely/very upsetting.
Cancer December 1, 2018 contributes to distress. Although we did not find an association between parent perception of information quality and distress, we do not have detailed information concerning what was said. Prior work in prognostic communication identified greater upset among parents who reported a lack of prognostic disclosure, and those who were dissatisfied with the quantity of information received. 18 Parents who believe they do not have enough information regarding the potential long-term implications of therapy may presume the worst and worry accordingly. Alternatively, distress may impair a parent's ability to process or remember the information presented. We previously found that parents who were upset by information regarding future limitations were less likely to understand their child's risk of impairment compared with parents who were less upset by such information, 25 suggesting that parental distress may have implications beyond the immediate emotionality of the information.
We also noted that parents who found information regarding long-term limitations distressing were more likely to find prognostic information distressing, reinforcing the parallels between these types of information. Studies of prognostic disclosure have demonstrated that although a subset of parents find prognostic information quite upsetting, parents value prognostic information, and receiving information regarding prognosis does not diminish hope. 18, 21, 33 We hypothesized that the parents of children with good prognoses might be the most worried about future functional limitations, but prognosis was not found to be significantly associated with concerns about future limitations. We also found that a higher risk of functional impairment was not significantly associated with increased parental distress. Therefore, distress may reflect the emotional experience of the parent more than the medical reality for the child.
Parents expressed a strong desire for information they found distressing, but the results of the current study did not investigate how this information could be shared in a less upsetting way. Further research should explore how best to convey information regarding potential functional impairment in a way that accurately conveys risks while meeting the emotional needs of parents. Studies in which early conversations regarding the long-term effects of treatment were recorded either in audio or video format could be used to help identify best practices and explore the impact of spoken communication on distress. In the interim, clinicians should consider asking parents how much information they desire, and with what level of detail, and tailor their delivery of information accordingly.
The findings of the current study should be interpreted within the context of potential limitations. We surveyed the parents of children with many different cancer diagnoses with different risks of late effects, and some long-term limitations may be more distressing than others. We asked about general categories of future limitations as opposed to exploring distress associated with specific late effects, in part to address the varied late effects that patients might face, and because pilot testing revealed these functional outcomes to be more important to parents. The current study surveyed largely white, highly educated parents at 2 large pediatric cancer centers, raising concerns regarding generalizability. Future research should explore the unique information needs and preferences of more vulnerable populations. Although we did not capture the detailed content of the initial discussions between parents and providers, the majority of children with cancer are enrolled on clinical trials with standardized informed consent documents. 34 These documents often are used during discussions of the potential long-term effects of therapy, suggesting some uniformity of information provided across centers. We have limited information regarding parents who declined participation, and therefore we do not know whether they differed from the current study sample in meaningful ways. Last, the current study did not explore patient perspectives. Survivors of childhood cancer with unmet information needs regarding long-term outcomes are more likely to experience depression, anxiety, and inferior health-related quality of life. [35] [36] [37] In the current analysis, we focused on parents because they generally are the primary decision makers for their children, but adolescent and young adult patient perspectives concerning information delivery and distress associated with future limitations should be explored in future work.
Although emotional to learn about, parents desire early information regarding the long-term functional implications of cancer and its treatment. Risks of future impairment typically have been addressed in depth after treatment completion and during survivorship, yet parents wish to hear this information in early treatment discussions because they consider it germane to decision making. 9 Information regarding potential functional limitations also is crucial in preparing families for their children's future health needs. 20 Although many parents in the current study found information regarding future limitations to be upsetting, limited discussions of the long-term implications of cancer treatment do not meet parent preferences for early, detailed information. Best practices for these conversations must be investigated and tested so that we can impart difficult information honestly while also supporting its emotional impact.
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